Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey
A macaque monkey infected with NM-3, a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac (SIVmac) chimeric virus with env, rev, tat and vpu derived from HIV-1 and LTR, gag, pol, vif and vpx derived from SIVmac, became a long-term carrier (more than 2.8 years). This monkey produced neutralizing antibodies to the original NM-3 as well as to the parental HIV-1. The virus recovered at 116 weeks replicated more rapidly and productively in macaque peripheral blood mononuclear cells than the original virus. The recovered virus was not neutralized either by antibodies raised early in the monkey or by a neutralizing monoclonal antibody that recognizes the V3 loop of HIV-1 Env, whereas both the early antibodies and the monoclonal antibody neutralized the original NM-3. Analysis of the virus genomic population revealed a few common mutations in the V3 region that caused amino acid changes. These data are consistent with the hypothesis that the virus escaped from the early antibodies and that the observed mutations contributed to this, as with HIV-1-infected humans. The observed mutations could equally well be the result of adaptation to simian cells. These results suggest that the HIV-1-SIVmac chimeric virus will be useful for investigating genetic variation of HIV-1 env and alteration of biological properties in vivo in relation to the host immune response.
AlbertJ.,
AbrahamssonB.,
NagyK.,
AureliusE.,
GainesH.,
NyströmG.,
FenyöE. M.1990; Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107–112
BurnsD. W.,
DesrosiersR. C.1991; Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. Journal of Virology 65:1843–1854
BurnsD. W.,
CollignonC.,
DesrosiersR. C.1993; Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. Journal of Virology 67:4104–4113
ClaphamP. R.,
WeissR. A.,
DalgleishA. G.,
ExleyM.,
WhitbyD.,
HoggN.1987; Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology 158:44–51
de JongJ. J.,
de RondeA.,
KeuienW.,
TersmetteM.,
GoudsmitJ.1992a; Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology 66:6777–6780
de JongJ. J.,
GoudsmitJ.,
KeuienW.,
KlaverB.,
KroneW.,
TersmetteM.,
de RondeA.1992b; Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. Journal of Virology 66:757–765
GrimailaR. J.,
FullerB. A.,
RennertP. D.,
NelsonM. B.,
HammarskjöldM. -L.,
PottsB.,
MurrayM.,
PutneyS. D.,
GrayG.1992; Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. Journal of Virology 66:1875–1883
HolmesE. C.,
ZhangL. Q.,
SimmondsP.,
LudlamC. A.,
BrownA. J.1992; Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proceedings of the National Academy of Sciences, USA 89:4835–4839
HoxieJ. A.,
HaggartyB. S.,
BonserS. E.,
RackowskiJ. L.,
ShanH.,
KankiP. J.1988; Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. Journal of Virology 62:2557–2568
IvanoffL. A.,
LooneyD. J.,
McDanalC.,
MorrisJ. F.,
Wong-StaalF.,
LangloisA. J.,
PettewayS. R.Jr,
MatthewsT. J.1991; Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Research and Human Retroviruses 7:595–603
JavaherianK.,
LangloisA. J.,
SchmidtS.,
KaufmannM.,
CatesN.,
LangedijkJ. P.,
MeloenR. H.,
DesrosiersR. C.,
BurnsD. P.,
BolognesiD. P.,
LarosaG. J.,
PutneyS. D.1992; The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 89:1418–1422
KentK. A.,
RudE.,
CorcoranT.,
PowellC.,
ThiriartC.,
CollignonC.,
StottE. J.1992; Identification of two neutralizing and 8 nonneutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Research and Human Retroviruses 8:1147–1151
KirchhoffF.,
MoriK.,
DesrosiersR. C.1994; The V3′ domain is a determinant of simian immunodeficiency virus cell tropism. Journal of Virology 68:3682–3692
KuikenC. L.,
de JongJ. -J.,
BaanE.,
KeuienW.,
TersmetteM.,
GoudsmitJ.1992; Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. Journal of Virology 66:4622–4627
MasudaT.,
MatsushitaS.,
KurodaM. J.,
KannagiM.,
TakatsukiK.,
HaradaS.1990; Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of the third hypervariable env region. Journal of Immunology 145:3240–3246
MatsushitaS.,
Robert-GuroffM.,
RuscheJ.,
KoitoA.,
HattoriT.,
HoshinoH.,
JavaherianK.,
TakatsukiK.,
PutneyS.1988; Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. Journal of Virology 62:2107–2114
MiuraT.,
SakuragiJ. -I.,
KawamuraM.,
FukasawaM.,
MoriyamaE. N.,
GojoboriT.,
IshikawaK. -I.,
MingleJ. A. A.,
NettyV. B. A.,
AkariH.,
EnaniM.,
TsujimotoH.,
HayamiM.1990; Establishment of a phylogenetic survey system for AIDS related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS 4:1257–1261
OhtaY.,
MasudaT.,
TsujimotoH.,
IshikawaK.,
KodamaT.,
MorikawaS.,
NakaiM.,
HonjoS.,
HayamiM.1988; Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. International Journal of Cancer 41:115–122
OkaS.,
IdaS.,
ShiodaS.,
TakebeY.,
KobayashiN.,
ShibuyaY.,
OhyamaK.,
MomotaK.,
KimuraS.,
ShimadaK.1994; Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. AIDS Research and Human Retroviruses 10:271–277
ReitzM. S.,
WilsonC.,
NaugleC.,
GalloR. C.,
Robert-GuroffM.1988; Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell 54:57–63
Robert-GuroffM.,
AldrichK.,
MuldoonR.,
SternT. L.,
BansalG. P.,
MatthewsT. J.,
MarkhamP. D.,
GalloR. C.,
FranchiniG.1992; Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. Journal of Virology 66:3602–3608
RudenseyL. M.,
KimataJ. T.,
BenvenisteR. E.,
OverbaughJ.1995; Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207:528–542
SakuragiS.,
ShibataR.,
MukaiR.,
KomatsuT.,
FukasawaM.,
SakaiH.,
SakuragiJ.-l.,
KawamuraM.,
IbukiK.,
HayamiM.,
AdachiA.1992; Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. Journal of General Virology 73:2983–2987
ShibataR.,
KawamuraM.,
SakaiH.,
HayamiM.,
IshimotoA.,
AdachiA.1991; Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. Journal of Virology 65:3514–3520
TremblayM.,
WainbergM. A.1990; Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. Journal of Infectious Diseases 162:735–737
WillyR. L.,
SmithD. H.,
LaskeyL. A.,
TheodoreT. S.,
EarlyP. L.,
MossB.,
CaponD. J.,
MartinM. A.1988; In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of Virology 62:139–147
WolfsT. W.,
ZwartG.,
BakkerM.,
ValkM.,
KuikenC. L.,
GoudsmitJ.1991; Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 185:195–205
Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey